Indivior PLC Indivior to Host Capital Markets Day December 7 (7168F)
09 Noviembre 2022 - 2:30AM
UK Regulatory
TIDMINDV
RNS Number : 7168F
Indivior PLC
09 November 2022
Indivior to Host Capital Markets Day December 7, 2022 in New
York City
Slough, UK, and Richmond, VA, November 9, 2022 - Indivior PLC
(LON: INDV) today announced that it will be hosting a Capital
Markets Day on Wednesday, December 7, 2022, in New York City. The
event will be hosted by Mark Crossley, Chief Executive Officer,
along with members of the Indivior executive leadership team. The
focus of the event will be detailing the company's strategic growth
plans and roadmap for delivering long-term shareholder value.
The event will begin at 8:30 am EST and conclude at 12:30 pm
EST. Due to seating capacity, in-person participation is limited to
institutional investors and analysts.
For those wishing to attend in person, please RSVP to
investorrelations@indivior.com and further location details will be
provided. Remote participants will have the ability to ask
questions.
Further details about the Capital Markets Day can be found at
cmd.indivior.com .
To access the live webcast, please click INDV CMD 2022 .
A webcast replay will be available after the event has
concluded.
About Indivior
Indivior is a global pharmaceutical company working to help
change patients' lives by developing medicines to treat substance
use disorders (SUD) and serious mental illnesses. Our vision is
that all patients around the world will have access to
evidence-based treatment for the chronic conditions and
co-occurring disorders of SUD. Indivior is dedicated to
transforming SUD from a global human crisis to a recognized and
treated chronic disease. Building on its global portfolio of OUD
treatments, Indivior has a pipeline of product candidates designed
to both expand on its heritage in this category and potentially
address other chronic conditions and co-occurring disorders of SUD,
including alcohol use disorder and cannabis use disorder.
Headquartered in the United States in Richmond, VA, Indivior
employs approximately 1,000 individuals globally and its portfolio
of products is available in over 40 countries worldwide. Visit
www.indivior.com to learn more. Connect with Indivior on LinkedIn
by visiting www.linkedin.com/company/indivior .
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
-ends-
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEADFPESPAFFA
(END) Dow Jones Newswires
November 09, 2022 03:30 ET (08:30 GMT)
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024